Literature DB >> 23397066

Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green.

Andrew Ebenazer1, Simon Rajaratnam, Rekha Pai.   

Abstract

Mutation in VHL gene causes the von Hippel-Lindau (VHL) disease, a dominantly inherited familial cancer syndrome. The VHL mutation pattern includes point mutations, small deletions and large deletions. While most mutations can be identified during sequencing, large deletions often remain unnoticed in initial mutational screening. We evaluated the utility of a previously described real-time quantitative PCR (RQ-PCR) using SYBR Green for detection of larger deletions in the VHL gene and normalized the data using two reference genes with a normal copy number i.e., ZNF80 (3q13.31) and GPR15 (3q12.1). DNA sequencing was also done on all cases included in the study. SJNB-6 cell line demonstrating distal 3p loss was used as a positive control for deletion. Out of 21 individual cases included of VHL disease, 2 cases were found with partial deletion by RQ-PCR, with an exon 1 deletion, while PCR-sequencing identified 5 cases with base pair substitution and 1 with splice site variant which were not picked up by RQ-PCR. RQ-PCR proved to be fast, accurate and sensitive for identifying large deletions and can be incorporated into the routine work-up for detection of large deletions in VHL disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397066     DOI: 10.1007/s10689-013-9606-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

Review 1.  Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease.

Authors:  Frederik J Hes; Jo W M Höppener; Cornelis J M Lips
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease.

Authors:  Keiko Hattori; Jun-ichi Teranishi; Catherine Stolle; Minoru Yoshida; Kei-ichi Kondo; Takeshi Kishida; Hiroshi Kanno; Masaya Baba; Yoshinobu Kubota; Masahiro Yao
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

3.  Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients.

Authors:  P Mandich; M Montera; E Bellone; A Trojani; S Daniele; F Ajmar
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Somatic mosaicism in von Hippel-Lindau Disease.

Authors:  A Murgia; M Martella; C Vinanzi; R Polli; G Perilongo; G Opocher
Journal:  Hum Mutat       Date:  2000-01       Impact factor: 4.878

5.  Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.

Authors:  O M Sieber; H Lamlum; M D Crabtree; A J Rowan; E Barclay; L Lipton; S Hodgson; H J W Thomas; K Neale; R K S Phillips; S M Farrington; M G Dunlop; H J Mueller; M L Bisgaard; S Bulow; P Fidalgo; C Albuquerque; M I Scarano; W Bodmer; I P M Tomlinson; K Heinimann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

7.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  7 in total

1.  Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.

Authors:  Nilesh Lomte; Sanjeet Kumar; Vijaya Sarathi; Reshma Pandit; Manjunath Goroshi; Swati Jadhav; Anurag R Lila; Tushar Bandgar; Nalini S Shah
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

2.  Biological and clinical impact of central nervous system hemangioblastomas in Chinese patients with von Hippel-Lindau disease: implications for treatment.

Authors:  Liang Li; Zhiqiang Yi; Zhen Liu; Hongzhou Duan; Runchun Lu; Chunwei Li; Lei Li; Kan Gong
Journal:  Hered Cancer Clin Pract       Date:  2020-10-22       Impact factor: 2.857

Review 3.  Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.

Authors:  Dmitry S Mikhaylenko; Alexander S Tanas; Dmitry V Zaletaev; Marina V Nemtsova
Journal:  J Oncol       Date:  2020-06-17       Impact factor: 4.375

4.  Overexpression of EGFR and TGFα in von Hippel-Lindau-Related Central Nervous System Hemangioblastomas.

Authors:  Zhen Liu; Liang Li; Zhiqiang Yi; Hongzhou Duan; Runchun Lu; Chunwei Li; Jingcheng Zhou; Kan Gong
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

5.  Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.

Authors:  Bowen Zhou; Jiangyi Wang; Shengjie Liu; Xiang Peng; Baoan Hong; Jingcheng Zhou; Kaifang Ma; Jiufeng Zhang; Lin Cai; Kan Gong
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

6.  The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

Authors:  Kaifang Ma; Baoan Hong; Jingcheng Zhou; Yanqing Gong; Jiangyi Wang; Shengjie Liu; Xiang Peng; Bowen Zhou; Jiufeng Zhang; Haibiao Xie; Kenan Zhang; Lei Li; Desheng Cai; Zixin Wang; Lin Cai; Kan Gong
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

7.  Molecular Characterization of a Novel Germline VHL Mutation by Extensive In Silico Analysis in an Indian Family with Von Hippel-Lindau Disease.

Authors:  Gautham Arunachal; Divya Pachat; C George Priya Doss; Sumita Danda; Rekha Pai; Andrew Ebenazer
Journal:  Genet Res Int       Date:  2016-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.